Elucidating the specific pharmacological mechanism of action (MOA) of naturally developing compounds is often challenging. Although Tarselli et al. (60) made the very first de novo synthetic pathway to conolidine and showcased that this The natural way developing compound effectively suppresses responses to both of those chemically induced and infl… Read More